This event has passed.
Oligonucleotides for CNS Summit 2025
This event has passed.
Oligonucleotides for CNS Summit 2025
With Biogen’s milestone approval of Tofersen leading the charge with a first-in-class clinically effective ASO for ALS, the glass ceiling of efficacious and safe oligonucleotides for CNS indications has truly been shattered